| abstract |
The present invention relates to an aromatic ring or heteroaromatic ring compound, a process for the preparation thereof and a medical use thereof. In particular, the present invention relates to compounds of formula (I): The compound and the pharmaceutical composition comprising the compound are FXR activity-related diseases such as cholestasis syndrome, diabetes and its complications, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatosis hepatitis (NASH), obesity or metabolic syndrome (dyslipidemia, diabetes, diseases associated with abnormally high body weight index), cardiovascular diseases, and the like. The definition of each substituent of formula (I) is as described in the specification: [Formula I] . |